Back

Adiposity-related anthropometrics, cardiovascular outcomes, and finerenone in heart failure and chronic kidney disease with type 2 diabetes: a FINE-HEART analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Challenges of managing obesity in cardiovascular disease Obesity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
How excess fat affects cardiac electrophysiology: preclinical obesity, clinical obesity with cardiac arrhythmias and ECG features
Doctor N. Zhang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Childhood adiposity affects cardiac structure, function and disease risk in later life: evidence of a causal association
Doctor D. Du (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Beyond BMI: the predictive value of body roundness index for premature all-cause and cardiovascular mortality: a national cohort study of US adults under 65
Doctor S. Abohashem (Boston, US)
Abstract Slides Video
Presentation thumbnail
Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations
Doctor A. Cordero (Alicante, ES)
Abstract Slides Video
Presentation thumbnail
Implications of obesity and metabolic health on coronary heart disease: an analysis of 157,159 participants in the UK Biobank
Doctor R. Ananda (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges of managing obesity in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Trade-off of risk and benefit of finerenone across the spectrum of kidney function in patients with heart failure with mildly reduced and preserved ejection fraction in the FINEARTS-HF trial
thumbnail
Congress Presentation
Finerenone according to insulin resistance in heart failure: the FINEARTS-HF trial
thumbnail
Congress Presentation
Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources